Pfizer will move ahead with a pill version of a weight-loss drug as competition heats up for an oral medication that can rival Ozempic and other GLP-1 drugs.
Pfizer picks its pill in race for Ozempic-like weight-loss drug
Pfizer will move ahead with a pill version of a weight-loss drug as competition heats up for an oral medication that can rival Ozempic and other GLP-1 drugs.